Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Neudiva OD 250 Tablet

Prescription Icon
Prescription Required

Marketer

Arrient Healthcare Pvt Ltd

Salt Composition

Divalproex (250mg)

Overview Neudiva OD 250 Tablet

Epileptic seizures and migraines find management in the 250mg Neudiva OD Tablet. This medication effectively controls seizures and prevents migraine attacks. It also holds a role in treating bipolar disorder in certain cases. Dosage and frequency are personalized by your physician to optimize symptom control, administered either with or without food, consistently at the same time daily for maximum efficacy. Therapeutic effects typically manifest within a couple of weeks. Continuous use, as prescribed, is crucial; missed doses or abrupt cessation can exacerbate the condition and provoke seizures. Discontinuation should always be gradual. Common side effects, often mild, include headache, visual blurring, nausea, vomiting, dizziness, fatigue, imbalance, easy bruising, and hypothermia. Persistent or bothersome effects warrant medical consultation. Skin rashes demand immediate medical attention. Prolonged use may lead to osteoporosis and increased fracture risk. Suicidal ideation is a rare but potential adverse effect, necessitating immediate reporting of mood changes to your doctor. Prior to commencement, disclose any history of cardiac, renal, or hepatic disease, urinary difficulties, depression, or suicidal tendencies. Interactions with other medications are possible; therefore, comprehensive medication disclosure is vital. Pregnancy requires consultation before initiating or discontinuing treatment. Alcohol consumption should be avoided due to increased side effect risk and seizure potential. Regular blood tests monitor optimal dosage, both pre- and post-treatment initiation.

Uses of Neudiva OD 250 Tablet

Managing epilepsy and seizures | Bipolar disorder therapy | Migraine prophylaxis

Major Benefits of Neudiva OD 250 Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for Neudiva OD 250 Tablet. Ingest the tablet whole; avoid chewing, crushing, or breaking it. This medication can be administered with or without food, although consistent timing is recommended.

Common Side effects of Neudiva OD 250 Tablet:

  • Decreased body temperature
  • Dizziness
  • Sleepiness
  • Tremors
  • Paresthesia (tingling or pricking sensation)
  • Anemia (low number of red blood cells)
  • Decreased sodium level in blood
  • Liver injury
  • Gastrointestinal disturbance
  • Hypersensitivity
  • Deafness
  • Urinary incontinence
  • Increase in body weight
  • Pain during periods

How to use Neudiva OD 250 Tablet:

Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Neudiva OD 250 Tablet can be consumed with or without food, although consistent timing is recommended.

How Neudiva OD 250 Tablet works:

Epileptic seizures are managed by Neudiva OD 250mg tablets, an anticonvulsant drug that reduces heightened, irregular neuronal firing in the brain.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent use of Neudiva OD 250 Tablet and alcohol may result in significant sleepiness.

PregnancyPregnancyCONSULT YOUR DOCTOR

Taking Neudiva OD 250 Tablets during pregnancy is hazardous due to established risks to the fetus. Nevertheless, a physician might exceptionally prescribe it in critical circumstances where the potential advantages outweigh the dangers. Seek medical advice before use.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Lactation and the use of Neudiva OD 250 Tablets are compatible. Research in humans indicates minimal drug transfer to breast milk, posing no discernible risk to the infant.

DrivingDrivingUNSAFE

Driving ability may be impaired by the use of Neudiva OD 250 Tablets, which may produce adverse effects.

KidneyKidneySAFE IF PRESCRIBED

Renal impairment does not necessitate dosage modification for patients using Neudiva OD 250 Tablets; the medication is considered safe for this population.

LiverLiverUNSAFE

Patients with liver conditions should likely refrain from using Neudiva OD 250 Tablets due to potential safety concerns. A physician's advice is recommended.

What if you forget to take Neudiva OD 250 Tablet :

Should you forget a Neudiva OD 250 Tablet dose, take it immediately. If your next dose is imminent, however, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Neudiva OD 250 Tablet

LabelValue
Pharmaceutical Category Fatty acid-based compounds
Potential for Dependence None.
Type of Treatment Nervous system medications.
Mechanism of Action Drugs targeting sodium channels (anti-epileptic medications)

FAQs on Neudiva OD 250 Tablet

Discontinuing Neudiva OD 250 Tablet requires prior consultation with your physician. Dosage reduction should be gradual, overseen by a healthcare professional, before eventual cessation. Abrupt discontinuation may result in symptom relapse, including irritability, anxiety, dizziness, and tremors.
Neudiva OD 250 Tablets are occasionally employed to manage mood instability. Prescribing occurs for individuals exhibiting rapid mood fluctuations. The medication's mechanism involves mitigating heightened brain activity associated with these shifts.
Weight gain is a potential side effect of Neudiva OD 250 Tablet, possibly resulting from increased appetite. To mitigate this, maintain a healthy diet and regular exercise. Discuss any weight concerns with your physician.
Indeed, drowsiness can be a side effect of Neudiva OD 250 Tablet. Refrain from operating machinery or engaging in tasks demanding concentration until you've assessed its impact on your alertness.
Hair loss is a possible side effect of Neudiva OD 250 Tablet, typically temporary and dependent on dosage. If this side effect concerns you or continues, seek medical advice.
Liver injury is a potential adverse effect of Neudiva OD 250 Tablet. This risk is heightened within the initial six months of treatment. Indicators of liver damage can manifest as nausea, vomiting, anorexia, abdominal pain, dark urine, facial edema, and jaundice. Consequently, baseline liver function tests are recommended prior to commencing treatment, with subsequent periodic monitoring during the first six months, particularly for at-risk individuals and those with pre-existing hepatic conditions.
Refrain from drinking alcohol during your Neudiva OD 250 Tablet treatment course. Concurrent alcohol use may increase drowsiness, lightheadedness, or dizziness.
Prior to commencing Neudiva OD 250 Tablet therapy, your physician might recommend preliminary blood work. This may encompass a complete blood count (including platelets), bleeding time assessment, and coagulation studies. These pre-treatment checks help mitigate the risk of unexpected bleeding or bruising. Furthermore, baseline liver function tests are also suggested before treatment begins. Regular monitoring of liver function is advised during the initial six months of treatment, particularly for patients deemed high-risk or with a history of liver conditions.
Sudden, intense stomach pain accompanied by nausea and vomiting could indicate pancreatitis. Seek immediate medical attention if you develop these symptoms. Your physician may order a serum amylase test. If the test confirms pancreatitis, the medication must be discontinued at once.
An excess of Neudiva OD 250 Tablet can lead to headaches, blurred vision resulting from constricted pupils, diminished reflexes, disorientation, and fatigue. Additional symptoms may include muscle weakness, convulsions, unconsciousness, altered behavior, and respiratory problems like rapid breathing, dyspnea, or chest discomfort. Seek immediate medical care if an overdose occurs.
Neudiva OD 250 Tablet
84
MRP 102
17% off